John Lawrence Wallace, Chief Scientific Officer at Antibe Therapeutics, holds 1.97M shares in Antibe Therapeutics (Ticker: ATBPF). Most recently, John Lawrence Wallace Sold $250,000 shares of Antibe Therapeutics on Dec 17, 2022 for an estimated value of 122.50K.
What is the percentage of profitable transactions made by John Lawrence Wallace?
The percentage of profitable transactions made by John Lawrence Wallace is 50%.
What is the average return per transaction made by John Lawrence Wallace?
The average return per transaction made by John Lawrence Wallace is -16.30%.
What stocks does John Lawrence Wallace hold?
John Lawrence Wallace holds: ATBPF stocks.
What was John Lawrence Wallace’s latest transaction?
John Lawrence Wallace latest transaction was an Informative Sell of $122.50K.
What was John Lawrence Wallace's most profitable transaction?
John Lawrence Wallace’s most profitable transaction was an Informative Buy of ATBPF stock on May 17, 2019. The return on the trade was 90.50%.
What is John Lawrence Wallace's role in Antibe Therapeutics?
John Lawrence Wallace's role in Antibe Therapeutics is Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.